Literature DB >> 3016341

Site of attachment of encephalomyocarditis virus on human erythrocytes.

G P Allaway, A T Burness.   

Abstract

Previous studies of the attachment of encephalomyocarditis (EMC) virus to human erythrocytes concluded that the glycophorins, a family of human erythrocyte sialoglycoproteins, act as EMC virus receptors. Evidence is presented that the major glycophorin species, glycophorin A, is the receptor for EMC virus attachment to human erythrocytes. Comparison of the structures of glycophorins A and B and sialoglycopeptides released by chymotrypsin and trypsin treatment of erythrocytes confirmed our previous suggestion (A. T. H. Burness and I. U. Pardoe, J. Gen. Virol. 64:1137-1148, 1983) that attachment of EMC virus to glycophorin A involves the region containing amino acids 35 to approximately 70 (numbered from the NH2 terminus), four of which (amino acids 37, 44, 47, and 50) are glycosylated. In addition, we provide evidence that the segment containing amino acids 35 to 39 with an oligosaccharide side chain on threonine-37 is particularly important for EMC virus attachment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016341      PMCID: PMC253260     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Chemical structure of attachment sites for viruses on human erythrocytes.

Authors:  B J Enegren; A T Burness
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

3.  The attachment of encephalomyocarditis virus to erythrocytes from several animal species.

Authors:  M A Angel; A T Burness
Journal:  Virology       Date:  1977-12       Impact factor: 3.616

4.  The polypeptide composition of the encephalomyocarditis virus particle.

Authors:  A T Burness; S M Fox; I U Pardoe
Journal:  J Gen Virol       Date:  1974-06       Impact factor: 3.891

5.  Particle weight and other biophysical properties of encephalomyocarditis virus.

Authors:  A T Burness; F W Clothier
Journal:  J Gen Virol       Date:  1970-03       Impact factor: 3.891

6.  Structural comparison of glycophorins and immunochemical analysis of genetic variants.

Authors:  H Furthmayr
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

Review 7.  The blood group MNSs-active sialoglycoproteins.

Authors:  D J Anstee
Journal:  Semin Hematol       Date:  1981-01       Impact factor: 3.851

8.  The rare phenotype En(a-) in a French-Canadian family.

Authors:  V Taliano; R M Guévin; D Hébert; G L Daniels; P Tippett; D J Anstee; W J Mawby; M J Tanner
Journal:  Vox Sang       Date:  1980-02       Impact factor: 2.144

9.  Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence.

Authors:  M Tomita; H Furthmayr; V T Marchesi
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

10.  Structure of the Ss blood group antigens, II: a methionine/threonine polymorphism within the N-terminal sequence of the Ss glycoprotein.

Authors:  W Dahr; K Beyreuther; H Steinbach; W Gielen; J Krüger
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980
View more
  11 in total

1.  The mechanism of production of multiple mRNAs for human glycophorin A.

Authors:  J Hamid; A T Burness
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  Persistent infection of K562 cells by encephalomyocarditis virus.

Authors:  I U Pardoe; K K Grewal; M P Baldeh; J Hamid; A T Burness
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells.

Authors:  Y M Jin; I U Pardoe; A T Burness; T I Michalak
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Interaction of gangliosides with proteins depending on oligosaccharide chain and protein surface modification.

Authors:  M Hirai; H Iwase; S Arai; T Takizawa; K Hayashi
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

5.  Reprogramming of red blood cell metabolism in Zika virus-infected donors.

Authors:  Alexis Catala; Mars Stone; Michael P Busch; Angelo D'Alessandro
Journal:  Transfusion       Date:  2022-03-14       Impact factor: 3.337

6.  Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane.

Authors:  Glòria Sánchez; Lluís Aragonès; M Isabel Costafreda; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Amino acid substitutions in VP2 residues contacting sialic acid in low-neurovirulence BeAn virus dramatically reduce viral binding and spread of infection.

Authors:  A S Manoj Kumar; Patricia Kallio; Ming Luo; Howard L Lipton
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 8.  Evolution of cell recognition by viruses: a source of biological novelty with medical implications.

Authors:  Eric Baranowski; Carmen M Ruiz-Jarabo; Nonia Pariente; Nuria Verdaguer; Esteban Domingo
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

Review 9.  Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication.

Authors:  Mehrdad Ghashghaeinia; Peter Dreischer; Thomas Wieder; Martin Köberle
Journal:  Cell Cycle       Date:  2020-12-11       Impact factor: 4.534

10.  Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.

Authors:  Stéphanie Bibert; Nicolas Guex; Joao Lourenco; Thomas Brahier; Matthaios Papadimitriou-Olivgeris; Lauro Damonti; Oriol Manuel; Robin Liechti; Lou Götz; Jonathan Tschopp; Mathieu Quinodoz; Peter Vollenweider; Jean-Luc Pagani; Mauro Oddo; Olivier Hügli; Frédéric Lamoth; Véronique Erard; Cathy Voide; Mauro Delorenzi; Nathalie Rufer; Fabio Candotti; Carlo Rivolta; Noémie Boillat-Blanco; Pierre-Yves Bochud
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.